Brief: Shilpa Medicare Launches NDA Bortezomib For Injection In US
03/04/2025 09:38
April 3 (Reuters) - Shilpa Medicare Ltd SHME.NS: SHILPA MEDICARE LTD - LAUNCHES NDA BORTEZOMIB FOR INJECTION3.5MG/1.4ML IN US Source text: ID:nBSEbbvGZs Further company coverage: SHME.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026